“The timing of infection demonstrates the need for more careful attention to postinsertion care and access of central venous catheters.” Klintworth et al (2014).
Klintworth, G., Stafford, J., O’Connor, M., Leong, T., Hamley, L., Watson, K., Kennon, J., Bass, P., Cheng, A.C. and Worth, L.J. (2014) Beyond the intensive care unit bundle: Implementation of a successful hospital-wide initiative to reduce central line–associated bloodstream infections. AJIC: American Journal of Infection Control. 42(6), p.685-687.
A multimodal hospital-wide central line–associated bloodstream infection (CLABSI) risk reduction strategy was implemented over a 20-month period at an Australian center. Reduced CLABSI rates were observed in both intensive care units (ICUs) (incidence rate ratio , 0.39; P < .001) and non-ICU wards (IRR, 0.54; P < .001). The median time to CLABSI onset was 7.5 days for ICU events and 13 days for non-ICU events. The timing of infection demonstrates the need for more careful attention to postinsertion care and access of central venous catheters.
Other intravenous and vascular access resources that may be of interest (External links – IVTEAM has no responsibility for content).
- Guide for intravenous chemotherapy and associated vascular access devices from Macmillan.
- CancerUK IV chemotherapy information.